Compare BNR & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNR | IINN |
|---|---|---|
| Founded | 2014 | 2018 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.3M | 32.4M |
| IPO Year | 2020 | 2021 |
| Metric | BNR | IINN |
|---|---|---|
| Price | $21.03 | $1.10 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 51.5K | ★ 166.3K |
| Earning Date | 11-20-2025 | 10-01-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $75,749,382.00 | $289,000.00 |
| Revenue This Year | $136.32 | N/A |
| Revenue Next Year | N/A | $2,582.74 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.56 | N/A |
| 52 Week Low | $2.18 | $0.40 |
| 52 Week High | $23.45 | $1.65 |
| Indicator | BNR | IINN |
|---|---|---|
| Relative Strength Index (RSI) | 73.84 | 57.54 |
| Support Level | $14.01 | $0.90 |
| Resistance Level | $23.45 | $1.00 |
| Average True Range (ATR) | 1.97 | 0.07 |
| MACD | 0.76 | 0.02 |
| Stochastic Oscillator | 80.20 | 82.22 |
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.